The author analyzes the challenges Mexico’s 2013 energy reforms pose to the current administration, as well as the limitations the United States-Mexico-Canada Agreement imposes on changes in Mexico’s energy policies.
Fellow David Gantz examines the potential impact of changes to rules on tariffs, customs and rules of origin issues in North America under the United States-Mexico-Canada agreement. https://doi.org/10.25613/sj2a-wy96.
If the United States-Mexico-Canada Agreement (USMCA) is approved, this modified and modernized version of NAFTA will govern most economic relationships in North America. David A. Gantz, the Will Clayton Fellow in Trade and International Economics, reviews the USMCA and discusses its positive and negative elements.
The director of the White House Office of Science and Technology Policy (OSTP) plays a central role in advising the president on the impact of science and technology on domestic and global affairs, and on federal funding of scientific research. This paper provides recommendations for the next president to consider when choosing a science advisor and establishing science and technology policy priorities. The project also offers guidance to the next science advisor for developing effective policy while serving in the White House. The recommendations are based on lessons learned from past presidential science advisors as well as feedback from more than 60 reviewers, including individuals who currently serve or have served the OSTP, the President’s Council of Advisors for Science and Technology, federal agencies, Congress or congressional staff, and nongovernmental organizations as well as policy scholars.
Neal F. Lane, Kirstin R.W. Matthews, Kenneth M. EvansSeptember 12, 2016
State "right to try" laws can give terminally ill patients early access to experimental drugs and medical devices — but they arguably make safety and efficacy secondary to speedy access.
Baker Institute Policy Report #64 highlights some of the central ethical issues pertaining to NTD policy development and argues that ethical considerations should be included in the policy development process.
Kirstin R.W. Matthews, Ana S. IltisFebruary 29, 2016
Baker Institute Policy Report #65 summarizes the key findings of the Baker Institute conference "The United States and Mexico: Addressing a Shared Legacy of Neglected Tropical Diseases and Poverty."
Jennifer R. Herricks, Kirstin R.W. Matthews, Peter J. HotezFebruary 15, 2016
This report describes the problems associated with unproven stem cell treatments, focusing on those without FDA approval undertaken by NFL players in the past five years.